A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
NCT07043751
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
216
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Tumors
Interventions
DRUG:
TQB6411 injection
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.